June 9, 2025 — A new independent, peer-reviewed study published in the journal Clinical Breast Cancer reinforces the impact of iCAD’s ProFound AI in clinical breast imaging, showing meaningful improvements in detection, diagnostic accuracy, and workflow efficiency for radiologists.

May 27, 2025 — A new study from Mount Sinai's Department of Radiation Oncology reveals that most new radiation oncologists are choosing to work in large metropolitan areas rather than in rural communities. The study, which appears in the latest edition of International Journal of Radiation Oncology, Biology, Physics, suggests this trend could make it harder for people living in less populated areas to get the cancer care they need. 

June 5, 2025 —  Hand-blown x-ray tubes dating back to 1897, a 1916 mechanical rectifier that delivered a high-voltage direct current to the x-ray tubes of the era and World War II medical imaging equipment are just a few of the historical artifacts on display at the ASRT Museum and Archives, which celebrates its 10th anniversary this month.  


As scientists working in a range of life science and applied industrial applications seek deeper insights into complex new materials and biological structures, three-dimensional X-ray microscopy (3D XRM), also known as micro-computed tomography (micro-CT), is transforming imaging technology. The technique provides non-destructive, qualitative and quantitative 3D analysis of the microscopic world, giving insight into internal structures and shedding light on the mechanisms and success of fabrication.

June 05, 2025 — Nano-X Imaging Ltd. has announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd, has received EU MDR CE (Conformité Européenne) mark certification for HealthOST, an SaMD (Software as a medical device) for bone health analysis, enabling its commercialization across Europe and ensuring compliance with the highest regulatory standards for medical software.

June 5, 2025 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, has updated its ArteraAI Prostate Test with new insights to help higher-risk patients optimize treatment decisions.

June 2, 2025 — Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for Clairity Breast, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025 – propelling a new era of precision medicine in breast cancer.

May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for clinicians now recommend considering fluoroestradiol (FES) positron emission tomography (PET) for systemic staging in patients with recurrent or metastatic lobular breast cancer.

May 29, 2025 — Hyperfine, Inc., producer of the world’s first FDA-cleared AI-powered portable MRI system for the brain — the Swoop system — has announced FDA clearance of its next-generation software.

May 27, 2025 — DeepLook Medical, a company advancing medical imaging through visual enhancement technology, recently announced that its flagship product, DL Precise, is now in commercial use at major healthcare institutions across the United States, including Cleveland Clinic, AdventHealth, Mayo Clinic, Geisinger and others.

This marks the continuation of DeepLook’s commercial rollout, following successful pilots and initial data confirming the platform’s potential to support clinical performance and streamline imaging workflows.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now